149,993 members

Skip to content. | Skip to navigation

Network navigation
 

Tocilizumab pre-made

Up to Pre-made MABS
January 16. 2017
Richard Sutton

What's the general consensus on charging for doses bought in which are not administered for whatever reason- i.e. bloods deranged, patient poorly etc. It seems that this is fair game in oncology setting, and my own feeling is that we've had to buy in meds in good faith at our risk, so charge. Anyone else any strong feelings? Cheers

Powered by Ploneboard